M&A Deal Summary |
|
|---|---|
| Date | 2006-12-04 |
| Target | St. Francis Medical Technologies |
| Sector | Medical Products |
| Buyer(s) | Kyphon |
| Sellers(s) | EW Healthcare Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 525M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Kyphon, located in Sunnyvale, California, develops, manufactures and markets minimally invasive medical devices, which employ a proprietary balloon technology, to help surgeons repair spine fractures caused by osteoporosis, cancer and trauma. Approximately 700,000 of these fractures, also known as vertebral compression fractures ('VCF'), are diagnosed each year in the U.S. Left untreated, they can result in significant pain, deformity and reduced respiratory function, as well as shortened life expectancy
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Medical Products) | 1 of 1 |
| Type (Add-on Acquisition) | 1 of 1 |
| State (California) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2006) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1985 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 52 |
| Sector (Medical Products) | 3 of 23 |
| Type (Add-on Acquisition) | 4 of 34 |
| State (California) | 3 of 16 |
| Country (United States) | 8 of 45 |
| Year (2006) | 4 of 4 |
| Size (of disclosed) | 4 of 22 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-07-18 |
Confluent Surgical
Waltham, Massachusetts, United States Confluent Surgical, Inc.develops products to address the need for surgical sealing and post-surgical adhesion prevention applications. |
Sell | $245M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-01-01 |
Oraya Therapeutics
Newark, California, United States Oraya Therapeutics is a privately held, development-stage medical technology company, pioneering noninvasive radiation treatments for inflammatory and neovascular diseases of the eye. |
Buy | - |
